Insights On Drug Development

  1. Can We Actually Decouple US-China Supply-Chain Integration? 3/12/2025

    The realities in 2024 suggest the answer is no, and our panel of speakers detail why that is the right answer.

  2. The Costs Of Disengagement From China 3/12/2025

    If we ever did implement (suffer through?) some rather large-scale “disengagement” between the U.S. and China in the biopharma industry realm, what costs would we incur?

  3. Back To Supply-Chain And Outsourcing Basics 3/12/2025

    Vince Kosewski, KALA BIO, and Kishore Hotha, Dr. Hotha’s Life Sciences, remind us that our recent outsourcing fears should remind us of the fundamentals for approaching supply-chain decision-making.

  4. The BIOSECURE Act Will Be Back… With A Dose Of Tariffs! 3/12/2025

    Biopharma executives Robert Discordia, CEO, Equulus Therapeutics, and Reza Oliyai, CEO, Oliyai Consulting, agree we may not have seen the last of the Act… or tariffs to compound industry challenges.

  5. Update On BIOSECURE Act… And Other Supply-Chain Concerns 3/12/2025

    Chief Editor Louis Garguilo provides a succinct update on the Act, and broadens the discussion to other challenges on the horizon.

  6. How High Drug Load Nanocrystalline Tablets Lower Pill Burden 3/12/2025

    We showcase the development of high drug load nanocrystal based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.

  7. Strategies For Engineering Mammalian Cells To Express Difficult Proteins 3/11/2025

    By leveraging cells equipped with an existing TARGATT™ landing pad, we demonstrate how inducible expression can be efficiently achieved within just 4-6 weeks after donor plasmid creation.

  8. Strategies For Engineering Mammalian Cells 3/11/2025

    Using cells with a pre-engineered TARGATT™ landing pad, we achieve inducible expression within just 4-6 weeks after donor plasmid creation, significantly reducing development time and effort.

  9. Innovations In Pregastric Absorption Drug Delivery And ODTs 3/10/2025

    Experts explore permeation enhancers for drug absorption, PBPK modeling for formulation design, and fast-dissolving ODTs shaping drug development.

  10. Intelligent Manufacturing Of mRNA Through The Power Of Process Analytical Technologies 3/10/2025

    Learn how predictive models can monitor key CQAs, such as RNA concentration and nucleoside triphosphate consumption, and explore RBP and MIT’s vision for revolutionizing biomanufacturing.